Cardiovascular effect of testosterone replacement therapy in aging male

Area of Science:

• Endocrinology
• Cardiology
• Men's Health

Background:

• Cardiovascular diseases (CVD) are a leading cause of death globally, with coronary heart disease being most common.
• Testosterone (T), an anabolic hormone, plays a role in male well-being, and its deficiency is increasingly linked to CVD.
• Low testosterone is associated with metabolic and inflammatory factors that negatively impact vascular health.

Purpose of the Study:

• To review the current understanding of the relationship between androgen deficiency and cardiovascular disease.
• To explore the impact of late-onset hypogonadism (LOH) on men's vascular health.
• To discuss the potential therapeutic role of androgens in managing vascular disease in aging men.

Main Methods:

• Review of clinical and epidemiological studies.
• Analysis of the interplay between androgen deficiency and CVD markers.
• Evaluation of the impact of testosterone levels on endothelial function and cardiovascular risk factors.

Main Results:

• Testosterone deficiency is associated with increased risks of CVD.
• Androgen deficiency correlates with adverse metabolic profiles, including higher glucose and cholesterol levels.
• Low T contributes to inflammation and arterial wall thickening, impairing endothelial function.

Conclusions:

• A significant link exists between androgen deficiency (hypogonadism) and increased cardiovascular disease risk in men.
• Late-onset hypogonadism is a critical factor in men's vascular health and requires further investigation.
• Therapeutic interventions with androgens may hold potential for treating vascular disease in men with testosterone deficiency.